speb/financial-data huggingface dataset:
Financial ratios for HIHO — annual report dated 2022-03-31
Total revenue: 1579182.6309067688
Gross profit: 481481.48148148146
Operating income: 72413.79310344828
Net income: 59642.40102171137
Capital expenditures: 15325.670498084291
Operating cash flow: -20945.08301404853
Depreciation & amortization: 140102.1711366539
Net tangible assets: 1183780.332056194
Owner earnings: 184418.901660281
Return on net tangible assets (%): 15.578811090732552
Capex to operating income (%): 21.164021164021165
Buffett classification: The Great
Stock price: 2.3
P/E ratio: 178.41928925910062
Shares outstanding: 4626676
Book value: 1183780.332056194
P/B ratio: 8.98929853101737
Market cap (USD): 10641354.799999999
Debt to equity: 0.12957169058150825
Current ratio: 2.377846391354689
Quick ratio: 1.9243535314550368
Effective tax rate (%): 17.78169014084507
COGS to revenue (%): 69.51071572988273
SG&A to revenue (%): 25.903760614638095
Free cash flow (dilution-adjusted): -49169.8595146871
Buyback yield (%): 0
Retained earnings: -291698.595146871
Inventory turnover: 3.657446808510638
Receivables turnover: 5.454344949272166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.8592539010023765
FCF margin (%): -3.113627173473514
Rule of 40 score: -3.113627173473514
Financial ratios for HIHO — annual report dated 2023-03-31
Total revenue: 1304713.3757961784
Gross profit: 400127.3885350319
Operating income: -60764.331210191085
Net income: -37324.84076433121
Capital expenditures: 10700.636942675159
Operating cash flow: 103057.32484076434
Depreciation & amortization: 145350.31847133758
Net tangible assets: 1045095.5414012739
Owner earnings: 97324.84076433121
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 4626676
Book value: 1046624.2038216561
P/B ratio: 8.001232466650437
Market cap (USD): 8374283.5600000005
Debt to equity: 0.25012171372930864
Current ratio: 2.6249692194040875
Quick ratio: 2.2770253632110316
COGS to revenue (%): 69.33216168717048
SG&A to revenue (%): 35.32513181019332
Free cash flow (dilution-adjusted): 80000
Buyback yield (%): 0
Retained earnings: -432611.46496815287
Inventory turnover: 5.025477707006369
Receivables turnover: 5.421916357861302
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.856444715943799
FCF margin (%): 6.13161491896114
Revenue growth (%): -17.380463142061654
Rule of 40 score: -11.248848223100513
Financial ratios for HIHO — annual report dated 2024-03-31
Total revenue: 807279.69348659
Gross profit: 218135.3767560664
Operating income: -98212.00510855683
Net income: -122477.65006385696
Capital expenditures: 13026.819923371648
Operating cash flow: 53001.27713920817
Depreciation & amortization: 96807.15197956577
Net tangible assets: 848659.0038314176
Owner earnings: -38697.318007662834
Return on net tangible assets (%): -4.5598194130925505
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 4626676
Book value: 847765.006385696
P/B ratio: 10.805846444471227
Market cap (USD): 9160818.48
Debt to equity: 0.2095510695992769
Current ratio: 2.5139431847797757
Quick ratio: 2.105811832160542
COGS to revenue (%): 72.97895902547064
SG&A to revenue (%): 39.18683752570796
Free cash flow (dilution-adjusted): 30523.627075351214
Buyback yield (%): 0
Retained earnings: -640485.312899106
Inventory turnover: 2.945721583652618
Receivables turnover: 5.044692737430168
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.279374415185135
FCF margin (%): 3.781047302641987
Revenue growth (%): -38.1258973455406
Rule of 40 score: -34.344850042898614
Financial ratios for HIHO — quarterly report dated 2024-09-30
Total revenue: 272458.1724581725
Gross profit: 107335.90733590734
Operating income: 14157.014157014159
Net income: 29729.72972972973
Capital expenditures: 0
Net tangible assets: 872458.1724581725
Owner earnings: 29729.72972972973
Return on net tangible assets (%): 3.407582239268328
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.81
P/E ratio: 70.42011175454546
Shares outstanding: 4626676
Book value: 870913.770913771
P/B ratio: 9.615514003428402
Market cap (USD): 8374283.5600000005
Debt to equity: 0.16669129599527116
Current ratio: 2.5568364611260055
Quick ratio: 2.07828418230563
Effective tax rate (%): 0
COGS to revenue (%): 60.60462919225318
SG&A to revenue (%): 34.199338686820965
Buyback yield (%): 0
Retained earnings: -631660.2316602317
Inventory turnover: 0.7187675070028011
Receivables turnover: 1.0681130171543896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.503964998632759
Rule of 40 score: 0
Financial ratios for HIHO — quarterly report dated 2024-12-31
Total revenue: 248582.47422680413
Gross profit: 86340.20618556702
Operating income: 515.4639175257732
Net income: 12886.59793814433
Capital expenditures: 0
Net tangible assets: 837500
Owner earnings: 12886.59793814433
Return on net tangible assets (%): 1.5386982612709648
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.95
P/E ratio: 175.02715308
Shares outstanding: 4626676
Book value: 836984.5360824742
P/B ratio: 10.779193415242494
Market cap (USD): 9022018.2
Debt to equity: 0.15150115473441111
Current ratio: 2.5571227080394925
Quick ratio: 2.1427362482369534
Effective tax rate (%): 0
COGS to revenue (%): 65.26697770865734
SG&A to revenue (%): 34.52566096423017
Buyback yield (%): 0
Retained earnings: -660309.2783505155
Inventory turnover: 0.8570456092579986
Receivables turnover: 0.9846860643185299
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.058088875980249796
Revenue growth (%): -8.763069213874921
Rule of 40 score: -8.763069213874921
Financial ratios for HIHO — quarterly report dated 2025-03-31
Total revenue: 191131.10539845758
Gross profit: 39203.08483290488
Operating income: -83804.62724935732
Net income: -40488.43187660668
Capital expenditures: 0
Net tangible assets: 805784.061696658
Owner earnings: -40488.43187660668
Return on net tangible assets (%): -5.0247248364970485
Buffett classification: The Gruesome
Stock price: 1.85
Shares outstanding: 4626676
Book value: 805526.9922879176
P/B ratio: 10.625777512047232
Market cap (USD): 8559350.6
Debt to equity: 0.12924844423168982
Current ratio: 2.7851803704907376
Quick ratio: 2.412739681507962
COGS to revenue (%): 79.48890383322124
SG&A to revenue (%): 64.35776731674511
Buyback yield (%): 0
Retained earnings: -698843.1876606684
Inventory turnover: 1.031413612565445
Receivables turnover: 1.4549902152641878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.066388760228502
Revenue growth (%): -23.111592644270047
Rule of 40 score: -23.111592644270047
Financial ratios for HIHO — annual report dated 2025-03-31
Total revenue: 952699.2287917738
Gross profit: 317480.71979434445
Operating income: -68766.06683804627
Net income: 14010.282776349613
Capital expenditures: 29820.05141388175
Operating cash flow: -46272.49357326478
Depreciation & amortization: 78277.63496143959
Net tangible assets: 805784.061696658
Owner earnings: 62467.86632390745
Return on net tangible assets (%): 7.752432604881161
Buffett classification: The Gruesome
Stock price: 1.85
P/E ratio: 610.9334648440367
Shares outstanding: 4626676
Book value: 805526.9922879176
P/B ratio: 10.625777512047232
Market cap (USD): 8559350.6
Debt to equity: 0.12924844423168982
Current ratio: 2.7851803704907376
Quick ratio: 2.412739681507962
Effective tax rate (%): 25.850340136054424
COGS to revenue (%): 66.67566109012412
SG&A to revenue (%): 40.542363734484624
Free cash flow (dilution-adjusted): -67095.11568123393
Buyback yield (%): 0
Retained earnings: -698843.1876606684
Inventory turnover: 4.31239092495637
Receivables turnover: 7.252446183953033
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.259996912150688
FCF margin (%): -7.042633567188343
Revenue growth (%): 18.0135257307323
Rule of 40 score: 10.970892163543958
Financial ratios for HIHO — quarterly report dated 2025-09-30
Total revenue: 151670.95115681234
Gross profit: 38688.94601542416
Operating income: -69665.80976863753
Net income: -47814.91002570694
Capital expenditures: 0
Net tangible assets: 768894.6015424164
Owner earnings: -47814.91002570694
Return on net tangible assets (%): -6.218655967903711
Buffett classification: The Gruesome
Stock price: 1.64
Shares outstanding: 4626676
Book value: 767994.8586118252
P/B ratio: 9.879947183129707
Market cap (USD): 7587748.64
Debt to equity: 0.08200836820083682
Current ratio: 3.4831358249772104
Quick ratio: 3.1513217866909753
COGS to revenue (%): 74.49152542372882
SG&A to revenue (%): 71.4406779661017
Buyback yield (%): 0
Retained earnings: -739074.5501285347
Inventory turnover: 1.2074175824175823
Receivables turnover: 1.2040816326530612
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.775906735751295
Revenue growth (%): -20.645595158036315
Rule of 40 score: -20.645595158036315
Financial ratios for HIHO — quarterly report dated 2025-12-31
Total revenue: 147429.3059125964
Gross profit: 37532.13367609254
Operating income: -62467.86632390745
Net income: -14781.491002570694
Capital expenditures: 0
Net tangible assets: 754627.2493573264
Owner earnings: -14781.491002570694
Return on net tangible assets (%): -1.9587804462612843
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 4626676
Book value: 752056.5552699228
P/B ratio: 9.781730893043925
Market cap (USD): 7356414.840000001
Debt to equity: 0.05434968381473253
Current ratio: 4.268364928909953
Quick ratio: 3.8726303317535544
COGS to revenue (%): 74.54228421970357
SG&A to revenue (%): 67.82911944202267
Buyback yield (%): 0
Retained earnings: -753727.5064267352
Inventory turnover: 1.2799401197604792
Receivables turnover: 1.027777777777778
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.059701492537313
Revenue growth (%): -2.7966101694915233
Rule of 40 score: -2.7966101694915233
Financial ratios for HIVE — annual report dated 2022-03-31
Total revenue: 211184029
Gross profit: 96911097
Operating income: 79280769
Net income: 79622129
Capital expenditures: 209863580
Operating cash flow: 66279290
Depreciation & amortization: 67021722
Net tangible assets: 388716971
Owner earnings: -63219729
Return on net tangible assets (%): -16.26369150731008
Capex to operating income (%): 264.70931431051076
Buffett classification: The Gruesome
Stock price: 10.65
P/E ratio: 35.77068686080976
Shares outstanding: 267430821
Book value: 389052565
P/B ratio: 7.3207029072022705
Market cap (USD): 2848138243.65
Debt to equity: 0.12415324391962304
Current ratio: 7.611580732621281
Quick ratio: 1.1117602801675819
Effective tax rate (%): 2.9449720873083294
Interest coverage ratio: 20.4853939627587
COGS to revenue (%): 54.11059375138638
SG&A to revenue (%): 8.384246234832464
Free cash flow (dilution-adjusted): -153316396
Buyback yield (%): 0
Retained earnings: -60243556
Inventory turnover: 0.6721920885697619
Receivables turnover: 31.24940777745898
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.605281376583342
FCF margin (%): -72.598480446644
Rule of 40 score: -72.598480446644
Financial ratios for HIVE — annual report dated 2023-03-31
Total revenue: 106318000
Gross profit: -30875000
Operating income: -52496000
Net income: -236423000
Capital expenditures: 40887000
Operating cash flow: 44782000
Depreciation & amortization: 81730000
Net tangible assets: 148748000
Owner earnings: -195580000
Return on net tangible assets (%): -131.48412079490143
Buffett classification: The Gruesome
Stock price: 3.29
Shares outstanding: 267430821
Book value: 148815000
P/B ratio: 5.91235696058865
Market cap (USD): 879847401.09
Debt to equity: 0.24121224338944328
Current ratio: 3.576036067279348
Quick ratio: 0.7193081324778915
Interest coverage ratio: -13.24987380111055
COGS to revenue (%): 129.04023777723435
SG&A to revenue (%): 20.33616132733874
Free cash flow (dilution-adjusted): -6425000
Buyback yield (%): 0
Retained earnings: -296666000
Inventory turnover: 2.0818677066419826
Receivables turnover: 11.366046611075475
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.335916416737458
FCF margin (%): -6.04319118117346
Revenue growth (%): -49.65623086961751
Rule of 40 score: -55.69942205079097
Financial ratios for HIVE — annual report dated 2024-03-31
Total revenue: 114465000
Gross profit: -26077000
Operating income: -53307000
Net income: 26500000
Capital expenditures: 76353000
Operating cash flow: 9640000
Depreciation & amortization: 63599000
Net tangible assets: 259412000
Owner earnings: 13746000
Return on net tangible assets (%): 5.298906758361217
Buffett classification: The Gruesome
Stock price: 3.37
P/E ratio: 34.00912704792453
Shares outstanding: 267430821
Book value: 259412000
P/B ratio: 3.4741718454427706
Market cap (USD): 901241866.77
Debt to equity: 0.11607789924907097
Current ratio: 6.8283565582835655
Quick ratio: 0.8693135736931358
Effective tax rate (%): 18.92305338840447
Interest coverage ratio: -17.62797619047619
COGS to revenue (%): 122.78163630804175
SG&A to revenue (%): 17.86834403529463
Free cash flow (dilution-adjusted): -75844000
Buyback yield (%): 0
Retained earnings: -270866000
Inventory turnover: 0.8694484827863528
Receivables turnover: 16.51969981238274
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.068451401508106
FCF margin (%): -66.25955532258769
Revenue growth (%): 7.662860475178239
Rule of 40 score: -58.596694847409445
Financial ratios for HIVE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.13
Shares outstanding: 267430821
Market cap (USD): 837058469.73
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HIVE — quarterly report dated 2024-12-31
Total revenue: 29229000
Gross profit: -12773000
Operating income: -20863000
Net income: 68160000
Capital expenditures: 55300000
Operating cash flow: -28464000
Depreciation & amortization: 18050000
Net tangible assets: 434360000
Owner earnings: 30910000
Return on net tangible assets (%): 7.116216962887926
Buffett classification: The Gruesome
Stock price: 2.85
P/E ratio: 2.795546654379401
Shares outstanding: 267430821
Book value: 434360000
P/B ratio: 1.7547146142600607
Market cap (USD): 762177839.85
Debt to equity: 0.05803250759738466
Current ratio: 10.40934711131987
Quick ratio: 1.6592296852982622
Effective tax rate (%): 0.18013268309828215
Interest coverage ratio: -49.79236276849642
COGS to revenue (%): 143.69975024804134
SG&A to revenue (%): 27.677991036299566
Free cash flow (dilution-adjusted): -94214000
Buyback yield (%): 0
Retained earnings: -351009000
Inventory turnover: 0.16104690843002079
Receivables turnover: 3.2804713804713805
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.648815346460746
FCF margin (%): -322.33056211297
Rule of 40 score: -322.33056211297
Financial ratios for HIVE — quarterly report dated 2025-03-31
Total revenue: 31161000
Gross profit: -9251000
Operating income: -19150000
Net income: 142000
Capital expenditures: 67211000
Operating cash flow: 40230000
Depreciation & amortization: 15743000
Net tangible assets: 449137000
Owner earnings: -51326000
Return on net tangible assets (%): -11.427693554527906
Buffett classification: The Gruesome
Stock price: 1.45
P/E ratio: 682.7019198063381
Shares outstanding: 267430821
Book value: 449137000
P/B ratio: 0.8633773001333669
Market cap (USD): 387774690.45
Debt to equity: 0.1228155328997611
Current ratio: 3.6647361159543337
Quick ratio: 0.9183104143608715
Effective tax rate (%): 95.69827325053014
Interest coverage ratio: -72.26415094339623
COGS to revenue (%): 129.68775071403357
SG&A to revenue (%): 31.76727319405667
Free cash flow (dilution-adjusted): -34160000
Buyback yield (%): 0
Retained earnings: -273862000
Inventory turnover: 0.22309076656398705
Receivables turnover: 2.650195611498554
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.112610358623918
FCF margin (%): -109.6242097493662
Revenue growth (%): 6.609873755516782
Rule of 40 score: -103.01433599384941
Financial ratios for HIVE — annual report dated 2025-03-31
Total revenue: 115279000
Gross profit: -39342000
Operating income: -65912000
Net income: -2996000
Capital expenditures: 155118000
Operating cash flow: 16634000
Depreciation & amortization: 64490000
Net tangible assets: 449137000
Owner earnings: -93624000
Return on net tangible assets (%): -20.845310005633024
Buffett classification: The Gruesome
Stock price: 1.45
Shares outstanding: 267430821
Book value: 449137000
P/B ratio: 0.8633773001333669
Market cap (USD): 387774690.45
Debt to equity: 0.1228155328997611
Current ratio: 3.6647361159543337
Quick ratio: 0.9183104143608715
Effective tax rate (%): 285.85607940446647
Interest coverage ratio: -28.782532751091704
COGS to revenue (%): 134.12763816480017
SG&A to revenue (%): 23.886397349040156
Free cash flow (dilution-adjusted): -168559000
Buyback yield (%): 0
Retained earnings: -273862000
Inventory turnover: 0.8535711525509809
Receivables turnover: 9.804303452968192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.15511091162505
FCF margin (%): -146.21830515531883
Revenue growth (%): 0.7111344078976106
Rule of 40 score: -145.5071707474212
Financial ratios for HIVE — quarterly report dated 2025-06-30
Total revenue: 45611000
Gross profit: -6192000
Operating income: 6836000
Net income: 35016000
Capital expenditures: 45882000
Operating cash flow: 10228000
Depreciation & amortization: 22011000
Net tangible assets: 560521000
Owner earnings: 11145000
Return on net tangible assets (%): 1.9883287156056597
Capex to operating income (%): 671.1819777647747
Buffett classification: The Gruesome
Stock price: 1.8
P/E ratio: 4.659163725585087
Shares outstanding: 267430821
Book value: 560521000
P/B ratio: 0.8588000767143427
Market cap (USD): 481375477.8
Debt to equity: 0.07176359137302617
Current ratio: 3.420521462518698
Quick ratio: 2.5244163368867514
Effective tax rate (%): 1.819711201458012
Interest coverage ratio: 23.73611111111111
COGS to revenue (%): 113.57567253513407
SG&A to revenue (%): 25.213216110148867
Free cash flow (dilution-adjusted): -42879000
Buyback yield (%): 0
Retained earnings: -238846000
Inventory turnover: 1.0945991632506444
Receivables turnover: 1.3212920046349943
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1869683515621066
FCF margin (%): -94.01021683365855
Revenue growth (%): 46.372067648663396
Rule of 40 score: -47.63814918499515
Financial ratios for HIVE — quarterly report dated 2025-09-30
Total revenue: 87253000
Gross profit: 4112000
Operating income: -9160000
Net income: -15797000
Capital expenditures: 37524000
Operating cash flow: -10612000
Depreciation & amortization: 38292000
Net tangible assets: 624599000
Owner earnings: -15029000
Return on net tangible assets (%): -2.406183807530912
Buffett classification: The Gruesome
Stock price: 4.03
P/E ratio: 12.314144132608174
Shares outstanding: 267430821
Book value: 624599000
P/B ratio: 1.7255010152593906
Market cap (USD): 1077746208.63
Debt to equity: 0.03706378012132584
Current ratio: 2.549222218077368
Quick ratio: 2.094788674599918
Interest coverage ratio: -27.926829268292682
COGS to revenue (%): 95.28726805955095
SG&A to revenue (%): 15.210938305846216
Free cash flow (dilution-adjusted): -53666000
Buyback yield (%): 0
Retained earnings: -254643000
Inventory turnover: 3.412452799211952
Receivables turnover: 5.13434153230552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4326894051367234
FCF margin (%): -61.50619462941103
Revenue growth (%): 91.29815176163645
Rule of 40 score: 29.79195713222542
Financial ratios for HIVE — quarterly report dated 2025-12-31
Total revenue: 93111000
Gross profit: -25276000
Operating income: -39173000
Net income: -91327000
Capital expenditures: 54908000
Operating cash flow: 45985000
Depreciation & amortization: 57420000
Net tangible assets: 559270000
Owner earnings: -88815000
Return on net tangible assets (%): -15.880522824396087
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 267430821
Book value: 559270000
P/B ratio: 1.2337002130992185
Market cap (USD): 689971518.1800001
Debt to equity: 0.03232606790995405
Current ratio: 1.7376503662338159
Quick ratio: 0.9324905811929851
Interest coverage ratio: -131.0133779264214
COGS to revenue (%): 127.14609444641343
SG&A to revenue (%): 16.587728624974492
Free cash flow (dilution-adjusted): -15996000
Buyback yield (%): 0
Retained earnings: -345970000
Inventory turnover: 2.8119759625662097
Receivables turnover: 6.303208773354996
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.851948379061966
FCF margin (%): -17.179495440925347
Revenue growth (%): 6.713809267303129
Rule of 40 score: -10.465686173622217
Financial ratios for HPAL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0208360807068442
Shares outstanding: 91874735
Market cap (USD): 93789044.39337993
Buyback yield (%): 0
Retained earnings: 14883885.005934328
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HPAL.NS — annual report dated 2023-03-31
Total revenue: 28379537.1498173
Gross profit: 7094799.025578563
Operating income: 1927783.1912302072
Net income: 1322545.6760048722
Capital expenditures: 1949646.7722289893
Operating cash flow: -614738.1242387333
Depreciation & amortization: 394031.66869671136
Net tangible assets: 18047783.191230208
Owner earnings: -233069.4275274058
Return on net tangible assets (%): -1.291401969193973
Capex to operating income (%): 101.13413069987554
Buffett classification: The Gruesome
Stock price: 0.8785627283800244
P/E ratio: 61.032083288512716
Shares outstanding: 91874735
Book value: 18061900.121802684
P/B ratio: 4.468949407673704
Market cap (USD): 80717717.85079172
Debt to equity: 0.05751030763068132
Current ratio: 3.2066270854754717
Quick ratio: 1.7186672858137917
Effective tax rate (%): 27.77445189442316
Interest coverage ratio: 7.8158518518518525
COGS to revenue (%): 75.00030043434222
SG&A to revenue (%): 4.547588799807722
Free cash flow (dilution-adjusted): -2564384.8964677225
Buyback yield (%): 0
Retained earnings: 2076589.5249695494
Inventory turnover: 3.8953578314998714
Receivables turnover: 6.254187424841092
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.2438257182024
FCF margin (%): -9.036034953389757
Rule of 40 score: -9.036034953389757
Financial ratios for HPAL.NS — annual report dated 2024-03-31
Total revenue: 28289483.151457008
Gross profit: 9648626.933685094
Operating income: 3168137.6663868567
Net income: 2466506.775392733
Capital expenditures: 1972934.4046048687
Operating cash flow: 2594543.7102770116
Depreciation & amortization: 514869.88847583643
Net tangible assets: 20229583.882959586
Owner earnings: 1008442.2592637006
Return on net tangible assets (%): 4.984987655199191
Capex to operating income (%): 62.27426369558388
Buffett classification: The Good
Stock price: 1.1323176583493282
P/E ratio: 42.17761971487004
Shares outstanding: 91874735
Book value: 20252943.998081304
P/B ratio: 5.136605562456531
Market cap (USD): 104031384.79666506
Debt to equity: 0.01873653333870174
Current ratio: 4.630161396499671
Quick ratio: 2.8258991063794365
Effective tax rate (%): 26.846773791994767
Interest coverage ratio: 34.789439030813796
COGS to revenue (%): 65.89323713682569
SG&A to revenue (%): 5.418853272065992
Free cash flow (dilution-adjusted): 621453.4116800575
Buyback yield (%): 0
Retained earnings: 4514905.864012471
Inventory turnover: 3.2595182627768144
Receivables turnover: 6.466686037905494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.431383784345782
FCF margin (%): 2.196764813103524
Revenue growth (%): -0.317320179976476
Rule of 40 score: 1.879444633127048
Financial ratios for HPAL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 20992462.9718108
Buffett classification: The Gruesome
Stock price: 1.084806497849976
Shares outstanding: 91874735
Book value: 21014166.268514093
P/B ratio: 4.742815310525855
Market cap (USD): 99666309.51624462
Debt to equity: 0.01657301231280971
Current ratio: 4.693916537302529
Quick ratio: 2.882388822938544
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HPAL.NS — quarterly report dated 2025-03-31
Total revenue: 7734650.455927051
Gross profit: 2836427.402384849
Operating income: 450116.9043722235
Net income: 419651.6249707739
Capital expenditures: 0
Depreciation & amortization: 146235.6792144026
Net tangible assets: 21525870.937573064
Owner earnings: 565887.3041851765
Return on net tangible assets (%): 2.628870654415331
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5561909207608823
P/E ratio: 30.441853679150444
Shares outstanding: 91874735
Book value: 21543102.64203881
P/B ratio: 2.3719839385900094
Market cap (USD): 51099893.45431206
Debt to equity: 0.04180330226281028
Current ratio: 3.5682477258820144
Quick ratio: 2.2018444481530124
Effective tax rate (%): 25.04593669088783
Interest coverage ratio: 6.50608313619466
COGS to revenue (%): 63.328305286099926
Buyback yield (%): 0
Retained earnings: 6200631.283610007
Inventory turnover: 0.741649246215145
Receivables turnover: 1.5849549275463002
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.061966641585823
Rule of 40 score: 0
Financial ratios for HPAL.NS — annual report dated 2025-03-31
Total revenue: 29201928.922141686
Gross profit: 10970879.12087912
Operating income: 2490472.293663783
Net income: 2132756.6050970303
Capital expenditures: 1609819.9672667757
Operating cash flow: 2002513.4440028055
Depreciation & amortization: 551554.8281505728
Net tangible assets: 21525870.937573064
Owner earnings: 1074491.4659808273
Return on net tangible assets (%): 4.991628302041519
Capex to operating income (%): 64.63914380266154
Buffett classification: The Good
Stock price: 0.5561909207608823
P/E ratio: 23.9595523146849
Shares outstanding: 91874735
Book value: 21543102.64203881
P/B ratio: 2.3719839385900094
Market cap (USD): 51099893.45431206
Debt to equity: 0.04180330226281028
Current ratio: 3.5682477258820144
Quick ratio: 2.2018444481530124
Effective tax rate (%): 23.114917145698826
Interest coverage ratio: 9.903077352175531
COGS to revenue (%): 62.43097793255463
SG&A to revenue (%): 6.418306655943133
Free cash flow (dilution-adjusted): 362660.7435118073
Buyback yield (%): 0
Retained earnings: 6200631.283610007
Inventory turnover: 2.7603978412210655
Receivables turnover: 5.983947355182434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.408749019303324
FCF margin (%): 1.2419068085493086
Revenue growth (%): 3.2253886216287553
Rule of 40 score: 4.467295430178064
Financial ratios for HPAL.NS — quarterly report dated 2025-06-30
Total revenue: 7735186.051954132
Gross profit: 2780166.159606834
Operating income: 599028.7853966769
Net income: 490732.5064357595
Capital expenditures: 0
Depreciation & amortization: 165059.67704189094
Owner earnings: 655792.1834776504
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6006318745611983
P/E ratio: 28.112512205815726
Shares outstanding: 91874735
Market cap (USD): 55182894.30786333
Effective tax rate (%): 24.733035409824296
Interest coverage ratio: 7.938129942626763
COGS to revenue (%): 64.05818630691522
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.00692463130858712
Rule of 40 score: 0.00692463130858712
Financial ratios for HPAL.NS — quarterly report dated 2025-09-30
Total revenue: 7334870.349492672
Gross profit: 2939729.425028185
Operating income: 553968.4329199549
Net income: 398387.82412626833
Capital expenditures: 0
Depreciation & amortization: 164013.52874859076
Net tangible assets: 21233912.06313416
Owner earnings: 562401.3528748591
Return on net tangible assets (%): 2.648599802065149
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.537880496054115
P/E ratio: 37.75877671257284
Shares outstanding: 91874735
Book value: 21248782.41262683
P/B ratio: 2.3256686937165183
Market cap (USD): 49417628.03664036
Debt to equity: 0.011300070512694674
Current ratio: 3.6627131856363335
Quick ratio: 2.2708523054282654
Effective tax rate (%): 26.391984502260087
Interest coverage ratio: 7.804479034307497
COGS to revenue (%): 59.92118081226185
Buyback yield (%): 0
Inventory turnover: 0.680183127367387
Receivables turnover: 1.5641751214117423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.574434731946945
Revenue growth (%): -5.175256286955481
Rule of 40 score: -5.175256286955481
Financial ratios for HPAL.NS — quarterly report dated 2025-12-31
Total revenue: 7281619.694775538
Gross profit: 2865656.678177565
Operating income: 272006.2381641974
Net income: 180706.24930377633
Capital expenditures: 0
Depreciation & amortization: 167706.36069956556
Owner earnings: 348412.6100033419
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.4586164642976496
P/E ratio: 28.288608713550463
Shares outstanding: 91874735
Market cap (USD): 42135266.12398352
Effective tax rate (%): 27.59328691305124
Interest coverage ratio: 3.7886733902249805
COGS to revenue (%): 60.64533993400351
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.7259931284377437
Rule of 40 score: -0.7259931284377437
Financial ratios for INCR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.48
Shares outstanding: 57152396
Market cap (USD): 370347526.08000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INCR — annual report dated 2022-12-31
Total revenue: 110421590.9090909
Gross profit: 44057670.45454545
Operating income: 11704545.454545455
Net income: 12732670.454545455
Capital expenditures: 5608522.7272727275
Operating cash flow: 14564488.636363637
Depreciation & amortization: 3323579.5454545454
Net tangible assets: 61682954.54545455
Owner earnings: 10447727.272727273
Return on net tangible assets (%): 16.93778670252943
Capex to operating income (%): 47.91747572815534
Buffett classification: The Good
Stock price: 3.3
P/E ratio: 14.812517725428947
Shares outstanding: 57152396
Book value: 148146875
P/B ratio: 1.2730805614360747
Market cap (USD): 188602906.79999998
Debt to equity: 0.48930250039790824
Current ratio: 1.6867954937180023
Quick ratio: 1.2183301941999047
Effective tax rate (%): 0.21212535924456
Interest coverage ratio: 2.8048199332834094
COGS to revenue (%): 60.10049294542611
R&D to revenue (%): 0.1625999526607733
SG&A to revenue (%): 25.037819925697995
Free cash flow (dilution-adjusted): 6425568.181818182
Buyback yield (%): 0
Retained earnings: -40241193.18181818
Inventory turnover: 1.5945678439296098
Receivables turnover: 2.9910273181993077
Capitalized R&D asset: 179545.45454545456
ROCI (R&D-adjusted, %): 6.443728841549006
FCF margin (%): 5.819122989369256
Rule of 40 score: 5.819122989369256
Financial ratios for INCR — annual report dated 2023-12-31
Total revenue: 98219060.77348065
Gross profit: 29031767.955801103
Operating income: 10384806.629834253
Net income: -17115745.856353592
Capital expenditures: 716574.585635359
Operating cash flow: -14815193.370165745
Depreciation & amortization: 3637016.574585635
Net tangible assets: 64649723.75690608
Owner earnings: -14195303.867403315
Return on net tangible assets (%): -21.957253708894513
Capex to operating income (%): 6.900220785784588
Buffett classification: The Great
Stock price: 1.29
Shares outstanding: 57152396
Book value: 126260220.99447514
P/B ratio: 0.5839257230765191
Market cap (USD): 73726590.84
Debt to equity: 0.4281191610766154
Current ratio: 1.8541980271663094
Quick ratio: 1.3836090105725467
Interest coverage ratio: 1.5522110739502042
COGS to revenue (%): 70.44181880057263
R&D to revenue (%): 0.10912578434157498
SG&A to revenue (%): 24.25433057800103
Free cash flow (dilution-adjusted): -16254696.132596685
Buyback yield (%): 0
Retained earnings: -56352209.94475138
Inventory turnover: 2.3563424937200703
Receivables turnover: 2.081960205647097
Capitalized R&D asset: 227477.77498744352
ROCI (R&D-adjusted, %): 6.70175591667718
Rosenberg metric: -83.68857087908245
FCF margin (%): -16.54943144903854
Revenue growth (%): -11.0508552133219
Rule of 40 score: -27.60028666236044
Financial ratios for INCR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 47226027.39726028
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 57152396
Book value: 108950958.9041096
P/B ratio: 0.8340661757734408
Market cap (USD): 90872309.64
Debt to equity: 0.5316052716944408
Current ratio: 1.727898566703418
Quick ratio: 1.1751841234840132
Buyback yield (%): 0
Retained earnings: -76049041.09589042
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INCR — annual report dated 2024-12-31
Total revenue: 65436986.30136987
Gross profit: 8283013.698630137
Operating income: -12344109.589041097
Net income: -18573972.602739725
Capital expenditures: 1198904.1095890412
Operating cash flow: -18335890.410958905
Depreciation & amortization: 4211232.876712329
Net tangible assets: 47226027.39726028
Owner earnings: -15561643.835616436
Return on net tangible assets (%): -32.95141406816533
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 57152396
Book value: 108950958.9041096
P/B ratio: 0.8340661757734408
Market cap (USD): 90872309.64
Debt to equity: 0.5316052716944408
Current ratio: 1.727898566703418
Quick ratio: 1.1751841234840132
Interest coverage ratio: -2.1824170501332043
COGS to revenue (%): 87.34200004186815
R&D to revenue (%): 0.1733341706964768
SG&A to revenue (%): 35.433440097134124
Free cash flow (dilution-adjusted): -20159726.02739726
Buyback yield (%): 0
Retained earnings: -76049041.09589042
Inventory turnover: 1.6645282777990555
Receivables turnover: 1.3232556593424858
Capitalized R&D asset: 244486.81223037918
ROCI (R&D-adjusted, %): -8.408324036964528
Rosenberg metric: -193.5837381725745
FCF margin (%): -30.807846092654227
Revenue growth (%): -33.376489465435824
Rule of 40 score: -64.18433555809005
Financial ratios for INVX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.68
Shares outstanding: 69820389
Market cap (USD): 1374065255.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INVX — annual report dated 2022-12-31
Total revenue: 467189000
Gross profit: 158117000
Operating income: 80455000
Net income: 63278000
Capital expenditures: 967000
Operating cash flow: -5811000
Depreciation & amortization: 24960000
Net tangible assets: 177513000
Owner earnings: 87271000
Return on net tangible assets (%): 49.163159881248134
Capex to operating income (%): 1.2019141134795848
Buffett classification: The Great
Stock price: 27.17
P/E ratio: 29.979139181548092
Shares outstanding: 69820389
Book value: 251280000
P/B ratio: 7.549426811246419
Market cap (USD): 1897019969.13
Debt to equity: 0.4559933142311366
Current ratio: 3.3214184897671135
Quick ratio: 1.7140908021641967
Effective tax rate (%): 13.233418804590766
Interest coverage ratio: 19.944224095190876
COGS to revenue (%): 66.15566719250667
SG&A to revenue (%): 12.67024694502653
Free cash flow (dilution-adjusted): -16293000
Buyback yield (%): 0.06815953553683402
Retained earnings: 71982000
Inventory turnover: 2.2616955105923675
Receivables turnover: 3.700975965270846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.90429475098643
FCF margin (%): -3.4874536857674303
Rule of 40 score: -3.4874536857674303
Financial ratios for INVX — annual report dated 2023-12-31
Total revenue: 555539000
Gross profit: 195437000
Operating income: 99981000
Net income: 73926000
Capital expenditures: 1410000
Operating cash flow: 75864000
Depreciation & amortization: 30059000
Net tangible assets: 263181000
Owner earnings: 102575000
Return on net tangible assets (%): 38.97507798815264
Capex to operating income (%): 1.410267950910673
Buffett classification: The Great
Stock price: 23.27
P/E ratio: 21.977659443632824
Shares outstanding: 69820389
Book value: 328921000
P/B ratio: 4.9395461281888355
Market cap (USD): 1624720452.03
Debt to equity: 0.25813797233986274
Current ratio: 3.6665097999313176
Quick ratio: 1.8707502893555321
Effective tax rate (%): 21.6603437678825
Interest coverage ratio: 18.158554304395206
COGS to revenue (%): 64.82029164469101
SG&A to revenue (%): 13.103850494744743
Free cash flow (dilution-adjusted): 58415000
Buyback yield (%): 0
Retained earnings: 145908000
Inventory turnover: 2.550514208006346
Receivables turnover: 4.548341670692069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.204637526249318
FCF margin (%): 10.515013347397753
Revenue growth (%): 18.91097607178251
Rule of 40 score: 29.42598941918026
Financial ratios for INVX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.68
Shares outstanding: 69820389
Market cap (USD): 1024963310.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INVX — annual report dated 2024-12-31
Total revenue: 660803000
Gross profit: 232631000
Operating income: 85243000
Net income: 140325000
Capital expenditures: 3247000
Operating cash flow: 93439000
Depreciation & amortization: 39524000
Net tangible assets: 789617000
Owner earnings: 176602000
Return on net tangible assets (%): 22.365526578075194
Capex to operating income (%): 3.8091104254894828
Buffett classification: The Great
Stock price: 13.97
P/E ratio: 6.950941274398718
Shares outstanding: 69820389
Book value: 958156000
P/B ratio: 1.0179875034232422
Market cap (USD): 975390834.33
Debt to equity: 0.09504506573042386
Current ratio: 3.9431875468774975
Quick ratio: 2.276051592912737
Effective tax rate (%): 1.741450298294261
Interest coverage ratio: 35.07942386831276
COGS to revenue (%): 64.79571067322635
SG&A to revenue (%): 17.58179063957034
Free cash flow (dilution-adjusted): 66597000
Buyback yield (%): 0
Retained earnings: 211250000
Inventory turnover: 1.5789625073292695
Receivables turnover: 2.401994140440412
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.237431449762036
FCF margin (%): 10.078192744282335
Revenue growth (%): 18.948084652922656
Rule of 40 score: 29.026277397204993
Financial ratios for INVX — quarterly report dated 2024-12-31
Total revenue: 250687000
Gross profit: 84870000
Operating income: 34553000
Net income: 31788000
Capital expenditures: 1194000
Operating cash flow: 36345000
Depreciation & amortization: 14592000
Net tangible assets: 789617000
Owner earnings: 45186000
Return on net tangible assets (%): 5.722521171656639
Capex to operating income (%): 3.455561022197783
Buffett classification: The Great
Stock price: 13.97
P/E ratio: 7.671061676812005
Shares outstanding: 69820389
Book value: 958156000
P/B ratio: 1.0179875034232422
Market cap (USD): 975390834.33
Debt to equity: 0.09504506573042386
Current ratio: 3.9431875468774975
Quick ratio: 2.276051592912737
Effective tax rate (%): -15.959581220588772
Interest coverage ratio: 92.14133333333334
COGS to revenue (%): 66.14503344808466
SG&A to revenue (%): 15.269240128127903
Free cash flow (dilution-adjusted): 27294000
Buyback yield (%): 0
Retained earnings: 211250000
Inventory turnover: 0.611480494001984
Receivables turnover: 0.9412186541414642
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.339018674655135
FCF margin (%): 10.887680653564006
Rule of 40 score: 10.887680653564006
Financial ratios for INVX — quarterly report dated 2025-03-31
Total revenue: 240415000
Gross profit: 76504000
Operating income: 29210000
Net income: 14757000
Capital expenditures: 1003000
Operating cash flow: 31090000
Depreciation & amortization: 17878000
Net tangible assets: 798062000
Owner earnings: 31632000
Return on net tangible assets (%): 3.9636018254220846
Capex to operating income (%): 3.4337555631633
Buffett classification: The Great
Stock price: 17.96
P/E ratio: 21.243718005692216
Shares outstanding: 69820389
Book value: 978376000
P/B ratio: 1.2816894388660391
Market cap (USD): 1253974186.44
Debt to equity: 0.08456053705323925
Current ratio: 4.338515556957598
Quick ratio: 2.492041503507773
Effective tax rate (%): 30.925856581164574
Interest coverage ratio: 41.72857142857143
COGS to revenue (%): 68.1783582555165
SG&A to revenue (%): 13.455483226920117
Free cash flow (dilution-adjusted): 22268000
Buyback yield (%): 0.04992128281182547
Retained earnings: 225382000
Inventory turnover: 0.6087665412570427
Receivables turnover: 0.8187071772029477
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.781417351626001
FCF margin (%): 9.262317243100473
Revenue growth (%): -4.097539960189399
Rule of 40 score: 5.164777282911073
Financial ratios for INVX — quarterly report dated 2025-06-30
Total revenue: 224234000
Gross profit: 71719000
Operating income: 27910000
Net income: 15345000
Capital expenditures: 7681000
Operating cash flow: 59210000
Depreciation & amortization: 18013000
Net tangible assets: 776689000
Owner earnings: 25677000
Return on net tangible assets (%): 3.3059564381625077
Capex to operating income (%): 27.520601934790395
Buffett classification: The Good
Stock price: 15.62
P/E ratio: 17.62149743383422
Shares outstanding: 69820389
Book value: 995553000
P/B ratio: 1.0954660135422223
Market cap (USD): 1090594476.1799998
Debt to equity: 0.0991338482230479
Current ratio: 4.597790661772273
Quick ratio: 2.686953240248379
Effective tax rate (%): 30.99028602266595
Interest coverage ratio: 50.653357531760435
COGS to revenue (%): 68.0160011416645
SG&A to revenue (%): 12.859334445266999
Free cash flow (dilution-adjusted): 48154000
Buyback yield (%): 0.7935121797345028
Retained earnings: 232078000
Inventory turnover: 0.5476399935366882
Receivables turnover: 0.8730901615088698
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5810663845465243
FCF margin (%): 21.47488784038103
Revenue growth (%): -6.730445271717656
Rule of 40 score: 14.744442568663374
Financial ratios for INVX — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.54
P/E ratio: 20.91565700533204
Shares outstanding: 69820389
Market cap (USD): 1294470012.06
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INVX — annual report dated 2025-12-31
Total revenue: 978251000
Gross profit: 303280000
Operating income: 113745000
Net income: 83298000
Capital expenditures: 100059000
Operating cash flow: 190912000
Depreciation & amortization: 73240000
Net tangible assets: 841749000
Owner earnings: 56479000
Return on net tangible assets (%): 6.709719880867099
Capex to operating income (%): 87.96782276144006
Buffett classification: The Gruesome
Stock price: 21.87
P/E ratio: 18.331435417777136
Shares outstanding: 69820389
Book value: 1057699000
P/B ratio: 1.4436733961457844
Market cap (USD): 1526971907.43
Debt to equity: 0.07496178024182683
Current ratio: 4.913791474312249
Quick ratio: 3.2370481358494643
Effective tax rate (%): 35.191279788997036
Interest coverage ratio: 44.053059643687064
COGS to revenue (%): 68.99773166600392
SG&A to revenue (%): 13.165639493340667
Free cash flow (dilution-adjusted): 141982000
Buyback yield (%): 0.6077387511089766
Retained earnings: 285274000
Inventory turnover: 2.716913614535911
Receivables turnover: 3.748145565449279
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.154507058473785
FCF margin (%): 14.513861984296463
Revenue growth (%): 48.03973347578628
Rule of 40 score: 62.55359546008274
Financial ratios for INVX — quarterly report dated 2025-12-31
Total revenue: 273602000
Gross profit: 79114000
Operating income: 31618000
Net income: 13968000
Capital expenditures: 1468000
Operating cash flow: 52238000
Depreciation & amortization: 18734000
Net tangible assets: 841749000
Owner earnings: 31234000
Return on net tangible assets (%): 3.710607318808814
Capex to operating income (%): 4.642924916186982
Buffett classification: The Great
Stock price: 21.87
P/E ratio: 34.648783921715456
Shares outstanding: 69820389
Book value: 1057699000
P/B ratio: 1.4436733961457844
Market cap (USD): 1526971907.43
Debt to equity: 0.07496178024182683
Current ratio: 4.913791474312249
Quick ratio: 3.2370481358494643
Effective tax rate (%): 48.203359661808875
Interest coverage ratio: 48.345565749235476
COGS to revenue (%): 71.08427569973904
SG&A to revenue (%): 11.708613241131278
Free cash flow (dilution-adjusted): 38282000
Buyback yield (%): 0
Retained earnings: 285274000
Inventory turnover: 0.7828589599610358
Receivables turnover: 1.0482995907983264
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8226753191333604
FCF margin (%): 13.991856784672626
Rule of 40 score: 13.991856784672626
Financial ratios for ISTR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.66
Shares outstanding: 13777385
Market cap (USD): 229531234.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ISTR — annual report dated 2022-12-31
Total revenue: 108393000
Net income: 35709000
Capital expenditures: 3636000
Operating cash flow: 42748000
Depreciation & amortization: 4435000
Net tangible assets: 172635000
Owner earnings: 36508000
Return on net tangible assets (%): 21.147507747559878
Buffett classification: The Gruesome
Stock price: 19.84
P/E ratio: 7.654745817581002
Shares outstanding: 13777385
Book value: 215782000
P/B ratio: 1.266756811967634
Market cap (USD): 273343318.4
Debt to equity: 2.0378900927788233
Effective tax rate (%): 19.48002164697393
COGS to revenue (%): 0
SG&A to revenue (%): 32.5076342568247
Free cash flow (dilution-adjusted): 39585000
Buyback yield (%): 3.855956700055925
Retained earnings: 108206000
Receivables turnover: 8.502078594399562
Capitalized R&D asset: 0
FCF margin (%): 36.519885970496254
Rule of 40 score: 36.519885970496254
Financial ratios for ISTR — annual report dated 2023-12-31
Total revenue: 82381000
Net income: 16678000
Capital expenditures: 1030000
Operating cash flow: 26247000
Depreciation & amortization: 3780000
Net tangible assets: 184448000
Owner earnings: 19428000
Return on net tangible assets (%): 10.533049965301872
Buffett classification: The Gruesome
Stock price: 14.17
P/E ratio: 11.705572937402566
Shares outstanding: 13777385
Book value: 226768000
P/B ratio: 0.8609042962410922
Market cap (USD): 195225545.45
Debt to equity: 0.3371286954067593
Effective tax rate (%): 18.357156843548072
COGS to revenue (%): 0
SG&A to revenue (%): 45.45344193442663
Free cash flow (dilution-adjusted): 23187000
Buyback yield (%): 1.5500020722313725
Retained earnings: 116711000
Receivables turnover: 5.734442433523597
Capitalized R&D asset: 0
FCF margin (%): 28.146053094766998
Revenue growth (%): -23.997859640382682
Rule of 40 score: 4.148193454384316
Financial ratios for ISTR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.77
Shares outstanding: 13777385
Market cap (USD): 258601516.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ISTR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.34
Shares outstanding: 13777385
Market cap (USD): 294009395.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ISTR — annual report dated 2024-12-31
Total revenue: 82409000
Net income: 20252000
Capital expenditures: 835000
Operating cash flow: 15927000
Depreciation & amortization: 3095000
Net tangible assets: 199600000
Owner earnings: 22512000
Return on net tangible assets (%): 11.278557114228457
Buffett classification: The Gruesome
Stock price: 21.34
P/E ratio: 14.517548681611693
Shares outstanding: 13777385
Book value: 241296000
P/B ratio: 1.2184594684536834
Market cap (USD): 294009395.9
Debt to equity: 0.38394751674292155
Effective tax rate (%): 17.020404818487258
COGS to revenue (%): 0
SG&A to revenue (%): 47.306726207089035
Free cash flow (dilution-adjusted): 13465000
Buyback yield (%): 0.10373818124633616
Retained earnings: 132935000
Receivables turnover: 5.713721139846079
Capitalized R&D asset: 0
FCF margin (%): 16.339234792316372
Revenue growth (%): 0.03398841965987303
Rule of 40 score: 16.373223211976246
Financial ratios for ISTR — quarterly report dated 2025-03-31
Total revenue: 20359000
Net income: 6293000
Capital expenditures: 215000
Operating cash flow: 4478000
Depreciation & amortization: 721000
Net tangible assets: 210179000
Owner earnings: 6799000
Return on net tangible assets (%): 3.2348617131112056
Buffett classification: The Gruesome
Stock price: 17.22
P/E ratio: 9.425018659621802
Shares outstanding: 13777385
Book value: 251737000
P/B ratio: 0.9424382180609127
Market cap (USD): 237246569.7
Debt to equity: 0.3395011460373326
Effective tax rate (%): 18.421052631578945
COGS to revenue (%): 0
SG&A to revenue (%): 47.71354192249128
Free cash flow (dilution-adjusted): 3813000
Buyback yield (%): 0.273555061647747
Retained earnings: 138197000
Receivables turnover: 1.333791928721174
Capitalized R&D asset: 0
FCF margin (%): 18.72881772189204
Rule of 40 score: 18.72881772189204